News

Endovascular Today2d
Borvo’s EVAC System Studied to Treat Chronic Subdural Hematoma
Borvo Medical, a portfolio company of NeuroTechnology Investors, announced findings for the company’s FDA-cleared endoport v ...
The Joplin Globe4h
Treatment with Next-Generation, Liquid Embolic NeoCast™ is Pain-Free and Leads to Rapid Resorption of Chronic Subdural Hematoma
Arsenal Medical, a clinical-stage company developing innovative biomaterials-based devices, today announced late-breaking data from the EMBO-02 clinical study for NeoCast™, a next-generation, ...
TMCnet2d
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
With clinical success demonstrated at Atlantic Health System, JFK University edical Center, Mount Sinai Health System, St. Lukes Health System, and University of Virginia, Borvo EVAC meets the ...
The Bakersfield Californian2d
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases ...
Borvo Medical, a neurosurgical medtech startup and a portfolio company of NeuroTechnology Investors (NTI), today announced a 100% success rate across ...